ArticleJAMA oncology2021

Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy Among Trial-Ineligible Patients With Advanced Solid Cancers.

Ravi B Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.